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Résumé Summary
Les voyages internationaux pour des soins médicaux, ou le 
tourisme médical,  créent  des  problèmes d’éthique  et  de 
sécurité pour les patients. Des lignes directrices pourraient 
être développées et  distribuées pour aider à répondre à 
ces  préoccupations,  mais  ils  peuvent  en  même  temps 
sembler entériner cette pratique.
International  travel  for  medical  care,  or  medical  tourism, 
creates ethical and safety concerns for patients. Guidelines 
could be developed and distributed to help address these 
concerns, but they may at the same time appear to endorse 
this practice.
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Introduction 
Medical tourism is a practice where patients travel internationally with the intention of receiving private 
medical  care,  usually  paid  for  out-of-pocket  [1].  Motivations  for  engaging  in  medical  tourism are 
diverse, and can include cost savings, avoiding wait times, enabling access to treatments unavailable 
locally  due to regulatory or safety restrictions (e.g.,  experimental  treatments such as the multiple 
sclerosis ‘liberation’ surgery), lack of specialists (e.g., hip resurfacing), or legal restrictions (e.g., organ 
purchases,  paid  surrogacy)  [2].  For  Canadian  patients,  wait  times  and  access  to  treatments 
unavailable domestically are thought to be primary drivers for pursuing medical tourism, though cost 
savings are also an important consideration for procedures not covered by the public system [3]. 
Indeed, a growing list of foreign medical institutions now provide access to quality health services for  
international patients, often at affordable prices. 
Services obtained via medical tourism may not be of the highest quality and the most safe, and thus 
raise important public health concerns within Canada when patients engaging in this practice return 
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home. Concerns include the domestic implications of inadequate access to follow-up care, exposure 
to and spread of infectious disease, disruptions to continuity of care, and exposure to poor quality or 
dangerous treatments abroad [2,4,5]. It is thought that medical tourism can also negatively impact the 
health of both the patient and the friends and family members they travel abroad with, increase care  
costs at home through the need for follow-up care for complications, and undermine health equity by 
allowing patients to exit the public health care system [1,4,5].
Case
Health policy implications
Given the public health concerns associated with medical tourism, there is a strong argument for 
implementing risk reduction interventions [4]1. Government and professional agencies, such as the 
Public Health Agency of Canada or the Canadian Medical Association, could develop guidelines for 
engaging in  medical  tourism in the safest  manner  possible (see [6]  for  a basic  example).  These 
guidelines  could  include  suggestions  that  patients:  1)  contact  their  family  physicians  or  relevant 
specialists before traveling abroad in order to seek advice on treatments and arrange for follow-up 
care and the exchange of medical records; 2) obtain necessary inoculations before traveling abroad in 
order to reduce the spread of infectious disease once home; 3) learn how to address complications 
upon the patient’s return; and 4) ensure that those traveling abroad with them as caregivers see their 
own doctors prior to departure for these same reasons. More ambitiously, guidelines could also: 5)  
rate specific countries or facilities based on quality of care; and 6) advise on procedures that present 
elevated levels of risk, including experimental treatments not approved in Canada.
Ethical implications
The creation and distribution of guideline statements about medical tourism by prominent Canadian 
health regulators and agencies raises significant ethical concerns. Rather than simply mitigating some 
of the negative impacts of medical tourism on public health, they might serve to raise the visibility of 
and legitimize this practice. First, they would increase the visibility of medical tourism, raising it as a 
new possibility for those who had not previously considered going abroad for care. Note that in order 
for these guidelines to be effective, they would need to be highly visible and easily accessed. Second, 
these guidelines may signal  to  patients that  medical tourism can be engaged in safely simply by 
following the advice that is offered. For example, a statement that provides a checklist of actions to 
take may easily be confused with a path to safely engaging in this practice.
Agencies considering offering guidelines on medical tourism are faced with the ethical question of 
whether or not the public health goals of these guidelines will  be achieved – or undermined – by 
distributing these guidelines.  Moreover,  creating guidelines raises the ethical  concern that  issuing 
agencies are complicit in a practice that undermines the goal of equitable access to medical care both 
domestically and abroad.2 By providing a means of opting out of the national health care system, 
medical tourism offers a second tier of care abroad for those who can afford it  and may increase 
pressure toward privatization within Canada [3]. There is the implicit risk that an issuing agency will be 
seen  as  endorsing the practice  of  purchasing medically  necessary private  care abroad,  which is 
something  that  goes  against  the  Canada  Health  Act,  which  states  that  health  care  should  be 
accessible to all. Whereas the intention of agencies may be to make an existing practice safer, the 
public may internalize the message that medical tourism is an ethically acceptable practice that can 
be engaged in with few risks. Therefore, public health agencies are left with a dilemma: Should they 
1 That is, strategies aimed at reducing the risk of harm to medical tourism participants and stakeholders. These interventions 
are common in response to drug abuse, including safe injection sites.
2 These agencies may be concerned in particular if the services being used by medical tourists are not widely available to 
the host country population or the treatments sought are not priorities for the host population.
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take action to reduce the health and safety risks of engaging in medical tourism, or focus on sending a 
message that medical tourism is potentially an unsafe practice that undermines health equity?
Responses to this case may depend on the type of medical tourism being engaged in by Canadians. 
Some forms of medical tourism are seen as being especially morally problematic. These include travel 
for organ transplantation where the organs are purchased in the destination country from vulnerable 
populations, and travel for reproductive treatments that involve paid surrogacy or the purchase of 
human gametes [7,8]. On the other hand, some forms of medical treatment will seem less ethically 
problematic  from  the  standpoint  of  condoning  privatisation.  As  dental  care  and  reproductive 
treatments not  involving purchased reproductive  tissues are already largely  privatised in  Canada, 
guidelines for seeking these treatments overseas would not necessarily undermine the public health 
care system as it  now exists.  Treatments paid for and available within Canada’s public Medicare 
system are likely to be the cases where the conflict in ethical values is greatest.
Questions
1. Can guidelines be crafted in a way that avoids complicity with the practice of medical tourism by  
Canadian patients?
• If so, what are the ethical and practical benefits of this guideline raising public awareness 
and visibility of medical tourism?
• If so, what venues should be sought to host this guideline in order for it to not be interpreted 
as an endorsement of the practice?
• If not, what are other means by which patients can become informed about medical tourism 
and its potential risks and benefits?
2. If a guideline for patients does not explicitly speak against involvement in medical tourism, should 
it also raise awareness about who holds responsibility for the harms and benefits created by this 
practice?
• If  so, which stakeholder groups hold responsibility  in causing and mitigating harms and 
benefits?
• If  so,  how can this  information be conveyed to potential  medical  tourists  in  a way that 
enables  an  understanding  of  their  own  ethical  and  practical  responsibilities  in  medical 
tourism should they choose to go abroad?
• If not, what are other means by which patients can become informed about their own and 
others’ practical and ethical responsibilities in medical tourism?
3. What ethical values should be drawn upon by the developing agency when deciding whether to 
create guidelines for Canadian patients thinking about engaging in medical tourism?
• How should these ethical values be determined? And must they be in keeping with the 
ethical values espoused by the agency that develops the guidelines?
• Are values focused on individuals relevant as well, including autonomy and confidentiality?
• Is there potential for ethical values to conflict with one another if the pursuit of treatment 
abroad by individuals threatens health equity?
4. What ethical values should patients draw upon when interpreting these guidelines?
• In what ways should their interpretation differ based upon the procedure they are thinking 
about obtaining abroad?
• Is there potential for patients’ own ethical values to conflict with the ethical values espoused 
by the guideline?
• In general, how much responsibility do patients have to inform themselves about the effects 
of medical tourism and why?
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5. How can guidelines help to ensure that patient confidentiality is protected during the exchange of 
patient records?
• In what ways might enabling patient confidentiality conflict with the need for the industry to 
share patient flow numbers and other details in  order to ensure adequate public health 
responses in patients’ home countries?
• What stakeholders hold responsibility in ensuring patient confidentiality in this globalized 
health service practice?
• How  can  the  potential  for  conflict  between  a  patient’s  expectations  of  confidentiality, 
confidentiality  legislation  in  the  destination  country,  and  confidentiality  legislation  in  the 
home country be resolved?
6. Guidelines may recommend the translation of medical records into other languages prior to and 
following travel abroad for care. 
• Who holds responsibility for paying for this translation?
• What confidentiality risks are posed in this particular recommendation? How can they be 
minimized?
• Recommending the translation of medical records implicitly implies that patients will be able 
to gain access to their  medical records at home and abroad. What are the ethical and 
practical barriers they may face in achieving this?
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